Fiche centre
University of Ottawa Heart Institute
Ottawa — Canada
Essais liés2clinical trials
VilleOttawalocalisation
PaysCanadalocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT07064473
Essais cliniques associés
2| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| 1/2 dose of 99mTc OR 201Tl tracers | SEP | Non applicable | NCT01412827 | SPECT-Light — Accuracy of Half of the Usual Radiotracer Dose in SPECT | COMPLETED |
| Vicadrostat | Hypertension | Phase 3 | NCT07064473 | EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease | RECRUITING |